PFIZER: $2.3 BILLIONAllegedly promoted unapproved uses for Bextra and other prescription drugs (September 2009)
QUEST DIAGNOSTICS: $302 MILLIONAllegedly sold inaccurate and unreliable laboratory test kits (April 2009)
ELI LILLY: $1.4 BILLIONPurportedly promoted unapproved uses for antipsychotic drug Zyprexa (January 2009)
BAYER HEALTHCARE: $97.5 MILLIONAllegedly paid kickbacks aimed at having patients switched to Bayer products (November 2008)
KYPHON: $75 MILLIONPurportedly persuaded hospitals to overbill for spinal procedures (May 2008)*
* Now owned by Medtronic Data: U.S. Justice Dept.